anti-PD1 treatmentimmune checkpoint therapyTNG260pembrolizumab
…t CoREST inhibition by TNG260 sensitizes STK11-mutant tumors to anti-PD1 treatment. TNG260, in combination with pembrolizumab, is being evaluated …
7,227articles mentioning treatments
16,644treatment mentions
4,719distinct treatments extracted
0%of mentions human-reviewed
All extracted treatments
Showing 2,881–2,940 of 4,719, ordered by supporting articles. Choose a treatment to see its evidence.
anti-rheumatic treatment1anti-seizure medications1anti-snake venom therapy1anti-staphylococcal antibiotic prophylaxis1anti-thrombotic therapy1anti-tuberculosis therapy1anti-tuberculous treatment1anti-tumor necrosis factor (TNF) therapy1anti-vascular endothelial growth factor1anti-vascular endothelial growth factor (VEGF) therapies1anti-vascular endothelial growth factor treatments1antiacid treatment1antiandrogen agents1antianginal therapy1antiangiogenic therapies1antiangiogenic therapy1antiarrhythmic and anticoagulation therapy1antiarrhythmic drug therapy1antibiotic plus bowel cleansing regimens1antibiotic prevention1antibiotic regimens1antibiotic therapies1antibiotic/adjunctive treatment strategies1antibody therapies1antibody-drug conjugate (ADC) therapies1antibody-drug conjugates1anticancer immunotherapy1anticancer treatments1anticholinesterase treatment1anticoagulant/antiplatelet therapy1anticoagulated1anticoagulation reversal1anticonvulsant therapy1antidepressant medication1antidepressant prescription1antidepressant therapy1antidepressants1antidiabetes therapies1antidiabetic therapies1antiepileptic drugs1antiepileptic medication treatments1antiepileptic therapy1antiepileptic treatment1antiepileptics1antifibrotic (AF) therapy1antifibrotic medications1antifibrotic therapies1antifungal and antibacterial therapy1antiglycemic intervention1antihypertensive drugs1antimetabolite therapy1antimigraine therapies1antineoplastic drug therapies1antiparasitic therapy1antiplatelet/anticoagulant treatment1antiproliferative therapy1antiproteinuric therapy1antireflux surgery1antiresorptive therapy1antiretroviral regimens1
Articles mentioning treatments
7,227 articles · page 231 of 603lymphodepleting chemotherapyAGX-148oral head and neck squamous cell carcinomamelanomathyroid cancersolid tumorsProvidence Institutional Review BoardClinicalTrials.gov
…ard and experimental therapies. Patients undergo tumor harvest, lymphodepleting chemotherapy, adoptive transfer of AGX-148 and high-dose IL-2 for one week, …
immunotherapyNanO 2Glioblastoma MultiformeNanO2PaclitaxelTNBCTriple-negative breast cancerDOD GrantBALB/c mice
… experiments, we tested the effect of NanO2 in combination with immunotherapy (IT), chemotherapy (CTX, paclitaxel) or both IT and CTX. BALB/c…
Triplet therapyanthracycline chemotherapyFTY720Flt3LTNBCDoxil D1NCT05029999
…s) as well as by blocking lymphocyte egress with FTY720.Results Triplet therapy significantly delayed tumor progression and extended median sur…
immunotherapyBreast cancerQUICKARRAYS, Inc
…y mapped the TME to identify features potentially predictive of immunotherapy response. FFPE (Formalin-Fixed Paraffin-Embedded) tissue slide …
T-FUSUniversity of Virginiacancerbreast cancerBCNIH DP5OD031846αCD40
…t of CD4+ T cells following rechallenge (figure 2O).Conclusions T-FUS+αCD40 represents a novel paradigm for immunotherapy of BC-capab…
anti-PD-1 therapyPD-1 therapyMD Anderson Cancer CenterKAN-001non-small cell lung cancerNSCLCCRCHUMCanadian Council
… evaluated in the MCA205 murine tumor model in combination with anti-PD-1 therapy. Comparative arms included treatment with FMT from ICI-non-resp…
immune checkpoint blockadeHER2-targeted therapyLeica BiosystemsIndica Labsgastric and gastroesophageal junction (GEJ) adenocarcinomaHER2-amplified colorectal cancerHER2-low breast cancerHER2-positive breast cancer
…, suggesting possible synergy between HER2-targeted therapy and immune checkpoint blockade.In HER2-amplified colorectal cancer, PD-L1 expression and immun…
immunotherapychemotherapyMassachusetts General HospitalMGH Histopathology Research CoreTNBCImmunomedics/GileadSacituzumab govitecantriple-negative breast cancerhuman breast cancer
…ody drug conjugates to activate anti-tumor immunity and enhance immunotherapy response.Acknowledgements We gratefully acknowledge Immunomedic…
Adoptive CTL therapyimmunotherapymelanoma-specificExtramammary Paget’s disease (EMPD)IL-2EMPDmelanomaRadiother Oncolsolid tumorsEBV-related cancers+1 more
…es in solid tumors, yet limited data exist in the EMPD context. Adoptive CTL therapy, which involves the ex vivo expansion and activation of autolog…
ImmunotherapyAzaAzacytidineAMLAcute Myeloid Leukemia
… AML has remained largely unchanged over the last four decades. Immunotherapy is a promising therapy in many cancers including AML. T cell ex…
immunotherapyEwing SarcomaChildren’s Oncology GroupIL1RAP
…on of the immune environment in ES may reveal the blockades for immunotherapy efforts and potential new pathways to be exploited in the futur…